We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a before-and-after study to evaluate your digital health product.
How to use an interrupted time series to evaluate your digital health product.
How to use a quasi-experimental study to evaluate your digital health product.
How to use a case-control study to evaluate your digital health product.
Terms of reference for two VfM studies that the OVfM will undertake with departments on high-risk areas of cross-departmental spending.
How to use a cost utility analysis to evaluate your digital health product.
How to use an ethnographic study to evaluate your digital health product.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).